Washington, D.C. (May 9, 2022) – Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, issued the following statement after a staff briefing by Dr. Peter Marks, Director for the Center of Biologics Evaluation and Research at the Food and Drug Administration (FDA), on the status of coronavirus vaccine candidates for young children that took place on the afternoon of May 6. The briefing followed Chairman Clyburn’s April 25 letter to FDA Commissioner Dr. Robert M. Califf after reports emerged that the agency was considering delaying its review of the first coronavirus vaccine for children...